Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a complex condition that can lead to serious health issues, but early diagnosis and treatment can reduce these risks.

Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

Presurgical models can effectively and affordably screen cancer prevention agents.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Cancer prevention is crucial, with a focus on research and improved screening methods.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Adding a second method to PROTACs could improve cancer treatment.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

Hormonal contraceptives are highly effective but require medical evaluation due to potential health risks.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Diagnosing mycosis fungoides, a rare skin cancer, is difficult in elderly adults and requires careful examination to avoid mistaking it for less serious skin conditions.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

The conclusions are: fecal short-chain fatty acids may help prevent cancer, fiber intake can reduce obesity, weight loss is hard for obese people, low BMI cancer patients are more prone to chemotherapy side effects, intermittent fasting benefits gut health, cherry laurel has health benefits in rats, certain gene variations can increase stress in hair loss patients, fecal acids can affect blood sugar levels, cold agglutinin can affect blood test results in autoimmune patients, and people with Crohn's disease have higher levels of a certain chemical in their blood.

More research is needed to understand how adipose-derived stem cells affect liver cancer treatment.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.